(Adds details on Austria)
FRANKFURT, Jan 22 (Reuters) - AstraZeneca has informed the European Commission that it will initially not be able to deliver the agreed volumes of its COVID-19 vaccine when it obtains regulatory approval for the bloc, which is expected by end-January, German newspaper Bild reported on Friday, citing company sources.
An AstraZeneca spokesman did not have an immediate comment when contacted by Reuters.
Austrian news site OE24 also reported of the looming delivery delays, saying that Astra had told the EU’s vaccination coordinators on Thursday that planned deliveries would be considerably below target during the first quarter.